UBS Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-468
| Closed | -$1K | – | 10473 |
|
|
2022
Q1 | $1K | Sell |
468
-10,750
| -96% | -$23K | ﹤0.01% | 9080 |
|
|
2021
Q4 | $26K | Buy |
+11,218
| New | +$26K | ﹤0.01% | 6461 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$4K | – | 9236 |
|
|
2021
Q2 | $4K | Sell |
500
-2,112
| -81% | -$16.9K | ﹤0.01% | 7643 |
|
|
2021
Q1 | $21K | Buy |
+2,612
| New | +$21K | ﹤0.01% | 6342 |
|
|
2020
Q4 | – | Sell |
-95
| Closed | -$1K | – | 7819 |
|
|
2020
Q3 | $1K | Sell |
95
-2,924
| -97% | -$30.8K | ﹤0.01% | 7002 |
|
|
2020
Q2 | $22K | Sell |
3,019
-6,657
| -69% | -$48.5K | ﹤0.01% | 5662 |
|
|
2020
Q1 | $60K | Sell |
9,676
-4,350
| -31% | -$27K | ﹤0.01% | 4808 |
|
|
2019
Q4 | $70K | Buy |
14,026
+10,172
| +264% | +$50.8K | ﹤0.01% | 5144 |
|
|
2019
Q3 | $29K | Buy |
3,854
+2,944
| +324% | +$22.2K | ﹤0.01% | 5557 |
|
|
2019
Q2 | $11K | Buy |
+910
| New | +$11K | ﹤0.01% | 6162 |
|